Opko Health, Inc. Uncategorized Contracts & Agreements

25 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated May 9. 2022, by and between the Company and Dr. Nabel
Opko Health, Inc.
Biotechnology
FL
2022
Offer Letter, dated May 9, 2022, by and between the Company and Dr. Zerhouni
Opko Health, Inc.
Biotechnology
FL
2022
Description of Securities
Opko Health, Inc.
Biotechnology
2021
Description of Securities
Opko Health, Inc.
Biotechnology
2020
Commitment Letter by and between OPKO Health, Inc. and Veterans Accountable Care Group, LLC, dated August 15, 2017
Opko Health, Inc.
Biotechnology
FL
2017
ARRANGEMENT AGREEMENT BY AND AMONG OPKOHEALTH, INC., OPKO GLOBAL HOLDINGS, INC. AND TRANSITIONTHERAPEUTICS INC. Dated as of June 29, 2016 TABLE OF CONTENTS
Opko Health, Inc.
Biotechnology
DE
2016
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
FL
2011
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
2011
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
FL
2011
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
DE
2011
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
FL
2010
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
DE
2010
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
2010
R E C I T A L S
Opko Health, Inc.
Biotechnology
DE
2009
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
CA
2009
We have a history of operating losses and we do not expect to become profitable in the near future
Opko Health, Inc.
Biotechnology
FL
2009
EX-31.1 Section 302 Certification of CEO
Opko Health, Inc.
Biotechnology
FL
2009
EX-31.1 Section 302 Certification of CEO
Opko Health, Inc.
Biotechnology
FL
2009
AMENDED AND RESTATED BYLAWS OF OPKO HEALTH, INC. (A DELAWARE CORPORATION) Effective: March 28, 2008 Article I. OFFICES
Opko Health, Inc.
Biotechnology
2008
EXEGENICS INC. 4400 Biscayne Blvd. Suite 900 Miami, Florida 33137
Opko Health, Inc.
Biotechnology
FL
2007
EXEGENICS INC. 4400 Biscayne Blvd Suite 900 Miami, Florida 33137
Opko Health, Inc.
Biotechnology
FL
2007
University of Pennsylvania
Opko Health, Inc.
Biotechnology
PA
2007
University of Pennsylvania
Opko Health, Inc.
Biotechnology
PA
2007
FORM OF LOCKUP AGREEMENT
Opko Health, Inc.
Biotechnology
2007
EX-10.2 Agreement Between eXegenics and D. Hostelley
Opko Health, Inc.
Biotechnology
2005